CAPLIPOINT

Caplin Point Laboratories Share Price Caplin Point Laboratories

₹1,331.15
-4.85 (-0.36%)
25 April, 2024 09:16 BSE: 524742 NSE: CAPLIPOINTISIN: INE475E01026

Start SIP in Caplin Point Laboratories

Start SIP

Caplin Point Laboratories Performance

Day Range

  • Low 1,325
  • High 1,339
₹ 1,331

52 Week Range

  • Low 647
  • High 1,619
₹ 1,331
  • Open Price1,339
  • Previous Close1,336
  • Volume1782

Caplin Point Laboratories Share Price

  • Over 1 Month +4.92%
  • Over 3 Month -10.05%
  • Over 6 Month +33.46%
  • Over 1 Year +102.9%

Caplin Point Laboratories Key Statistics

P/E Ratio 23.1
PEG Ratio 1
Market Cap Cr 10,109
Price to Book Ratio 5.5
EPS 30.7
Dividend 0.3
Relative Strength Index 52.17
Money Flow Index 53.63
MACD Signal -16.88
Average True Range 42.38
Caplin Point Laboratories Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 133179174145
Operating Expenses Qtr Cr 70909780
Operating Profit Qtr Cr 63897765
Depreciation Qtr Cr 7776
Interest Qtr Cr 0000
Tax Qtr Cr 19252116
Net Profit Qtr Cr 55827654
IndicatorMar 2023
Total Revenue Annual Cr 628
Operating Expenses Annual Cr 309
Operating Profit Annual in Cr 220
Depreciation Cr 26
Interest Annual Cr 0
Tax Annual Cr 59
Net Profit Annual Cr 234
IndicatorMar 2023
Cash from Operating Activity Annual Cr 157
Cash from Investing Activity Annual Cr -87
Cash from Financing Annual Activity Cr -30
Net Cash Flow Annual Cr 40
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 1,140
Fixed Assets Annual Cr 200
Total Non Current Assets Annual Cr 639
Total Current Assets Annual Cr 664
Total Assets Annual Cr 1,303
IndicatorMar 2023
Book Value Per Share Annual Rs 150
ROE Annual % 21
ROCE Annual % 25
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 60
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 436410395389
Operating Expenses Qtr Cr 293273269265
Operating Profit Qtr Cr 142137127124
Depreciation Qtr Cr 14121111
Interest Qtr Cr 0000
Tax Qtr Cr 26302323
Net Profit Qtr Cr 117115103102
IndicatorMar 2023
Total Revenue Annual Cr 1,523
Operating Expenses Annual Cr 1,026
Operating Profit Annual in Cr 441
Depreciation Cr 45
Interest Annual Cr 1
Tax Annual Cr 74
Net Profit Annual Cr 376
IndicatorMar 2023
Cash from Operating Activity Annual Cr 271
Cash from Investing Activity Annual Cr -218
Cash from Financing Annual Activity Cr -28
Net Cash Flow Annual Cr 26
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 1,806
Fixed Assets Annual Cr 501
Total Non Current Assets Annual Cr 637
Total Current Assets Annual Cr 1,554
Total Assets Annual Cr 2,191
IndicatorMar 2023
Book Value Per Share Annual Rs 241
ROE Annual % 21
ROCE Annual % 24
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 34

Caplin Point Laboratories Technicals

EMA & SMA

Current Price
₹1,331.15
-4.85 (-0.36%)
pointer
  • Bullish Moving Average
  • ___
  • 13
  • Bearish Moving Average
  • ___
  • 3
  • 20 Day
  • ₹1,319.99
  • 50 Day
  • ₹1,345.20
  • 100 Day
  • ₹1,321.84
  • 200 Day
  • ₹1,210.62
  • 20 Day
  • ₹1,306.83
  • 50 Day
  • ₹1,381.84
  • 100 Day
  • ₹1,374.17
  • 200 Day
  • ₹1,200.17

Caplin Point Laboratories Resistance and Support

PIVOT
₹1,338.45
Resistance
First Resistance 1,351.90
Second Resistance 1,367.80
Third Resistance 1,381.25
RSI 52.17
MFI 53.63
MACD Single Line -16.88
MACD -7.31
Support
First Resistance 1,322.55
Second Resistance 1,309.10
Third Resistance 1,293.20

Caplin Point Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 54,577 3,010,467 55.16
Week 81,712 3,900,133 47.73
1 Month 143,928 7,261,178 50.45
6 Month 153,132 6,255,452 40.85

Caplin Point Laboratories Result Highlights

Caplin Point Laboratories Synopsis

NSE-Medical-Generic Drugs

Caplin Point Lab is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 528.61 Cr. and Equity Capital is Rs. 15.18 Cr. for the Year ended 31/03/2023. Caplin Point Laboratories Ltd. is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053.
Market Cap 10,146
Sales 630
Shares in Float 2.20
No of funds 127
Yield 0.34
Book Value 8.94
U/D Vol ratio 0.8
LTDebt / Equity
Alpha 0.22
Beta 0.66

Caplin Point Laboratories

Owner NameMar-24Dec-23Sep-23Jun-23
Promoters 70.62%70.62%70.63%70.63%
Mutual Funds 1.06%0.41%0.05%0.05%
Insurance Companies 0.13%
Foreign Portfolio Investors 3.33%2.84%3.09%2.68%
Financial Institutions/ Banks 0.01%0.01%
Individual Investors 17.59%18.36%18.31%18.58%
Others 7.4%7.77%7.78%8.05%

Caplin Point Laboratories Management

Name Designation
Mr. C C Paarthipan Chairman
Dr. Sridhar Ganesan Managing Director
Dr. R Nagendran Independent Director
Mr. S Deenadayalan Independent Director
Mr. D Sathyanarayanan Independent Director
Dr. C K Gariyali Independent Director

Caplin Point Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Caplin Point Laboratories Corporate Action

Date Purpose Remarks
2024-02-09 Quarterly Results
2023-11-09 Quarterly Results
2023-08-07 Quarterly Results, Final Dividend & A.G.M.
2023-05-27 Audited Results & Interim Dividend (Revised) per share(110%)Final Dividend
2023-02-11 Quarterly Results
Date Purpose Remarks
2023-06-09 INTERIM Rs.2.00 per share(100%)Interim Dividend
2022-05-24 INTERIM Rs.2.00 per share(100%)Interim Dividend
2021-05-19 INTERIM Rs.1.50 per share(75%)Interim Dividend

Caplin Point Laboratories FAQs

What is Share Price of Caplin Point Laboratories ?

Caplin Point Laboratories share price is ₹1,331 As on 25 April, 2024 | 09:02

What is the Market Cap of Caplin Point Laboratories ?

The Market Cap of Caplin Point Laboratories is ₹10109 Cr As on 25 April, 2024 | 09:02

What is the P/E ratio of Caplin Point Laboratories ?

The P/E ratio of Caplin Point Laboratories is 23.1 As on 25 April, 2024 | 09:02

What is the PB ratio of Caplin Point Laboratories ?

The PB ratio of Caplin Point Laboratories is 5.5 As on 25 April, 2024 | 09:02

Q2FY23